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INTRODUCTION
The  laryngeal  mask  airway  (LMA)  may  provide  a  better  airway,  with 
respect  to  ventilation  and  oxygenation,  than  a  conventional  mask  and 
oropharyngeal  airway.  In  addition,  the  LMA  has  been  successfully  used  to 
manage difficult airways as a ventilatory device by itself and as a conduit for 
tracheal intubation.
Propofol  appears  to  provide  the  best  conditions  for  LMA  insertion, 
although propofol frequently causes apnea, pain on injection and hypotension.
To overcome this problem and to examine a better method for Laryngeal 
mask airway insertion in uncoperative children – a method in which the onset 
of action is rapid but airway and spontaneous ventilation are well  maintained 
and a mode of drug administration other  than Intravenous injection are being 
evaluated.
Ketamine  is  well  known for  its  airway   maintaining  activity  as  well  as 
for  its  increase  in  heart  rate  and  cardiac  output,  which  are  favourable 
characteristics in paediatric anaesthesia.
Because  it  increases  airway  reflexes  however,  ketamine  has  been 
regarded  as  inappropriate  for  the  preparation  of  Laryngeal  mask  airway 
insertion.  To  take  advantage  of  airway  maintaining  activity  and  to  suppress 
increased airway reflexes, lidocaine spray was added to the preparation of the 
patients before the injection of ketamine.
The equipotent doses of propofol and ketamine for insertion of an LMA 
are  not  known,  especially  in  patients  premedicated  with  midazolam.  This 
study compares the effectiveness of lidocaine spray and Intravenous ketamine 
with Propofol for insertion of LMA in children.
AIM OF THE STUDY
The aim of the study was to compare ketamine and lidocaine spray with 
propofol for the insertion of laryngeal mask airway in children, based on the 
following parameters
 Conditions for LMA insertion
 Responses after LMA insertion
ANATOMY OF PAEDIATRIC AIRWAY
In  infants  and  young children  the  head  is  relatively  large  and  the  neck 
shorter  than  in  the  adult.  These  factors,  together  with  the  relatively  large 
tongue,  predispose to upper airway obstruction,  and probably account  for  the 
greater use of tracheal intubation in these patients.
The infant  glottis  is  situated opposite  to C3 – C4 intervertebral  disk.  By 
the age of 3 years it has descended to the C 4 – C5 interspace, where it remains 
until puberty, when it descends again to lie opposite the body of C5.
The  epiglottis  of  the  infant  is  longer  and  U  –  shaped  posteriorly  as 
opposed  to  the  flat  leaf  –  shape  of  the  adult.  Infant  larynx  occupies  a  more 
anterior position compared with that in adults.
The  larynx  is  funnel  shaped  in  children  below 8  years  of  age  with  the 
narrowest  portion being at  the level  of  the cricoid  cartilage.  The  vocal  cords 
of  the  neonate  are  slanted  such  that  the  anterior  commissure  is  more  caudal 
than the posterior commissure.
Airflow  in  the  upper  airway  is  turbulent  during  quiet  respiration.  Laminar 
flow  begins  only  at  the  level  of  the  4 th or  5 th bronchial  divisions  where  the 
rapid increase in cross – sectional area increases airflow velocity.
They  have  highly  complaint  chest  wall  and  horizontally  placed  ribs, 
which  place  them  at  a  mechanical  disadvantage  and  increase  their  work  of 
breathing.
Diaphragm  is  the  major  muscle  of  respiration  in  the  neonate,  but  its 
muscle  fibers  are  such  that  they  are  less  efficient.  This  implies  that  airway 
obstruction will produce hypoxia more rapidly than in the adult.  
The  LMA  can  be  used  in  children,  including  small  infants.  It  may  be 
particularly  helpful  with  children  in  whom unusual  anatomy  makes  tracheal 
intubation difficult.
Studies  show fewer  hypoxic  episodes  and improved surgical  conditions 
in children ventilated with the LMA compared to a face mask.
The  LMA  has  been  successfully  used  for  neonatal  resuscitation  in 
infants as small as 1.2kg and neonates with abnormal airways.
LARYNGEAL MASK AIRWAY
The  standard  LMA  consists  of  a  curved  tube  (shaft)  connected  to  an 
elliptical  mask at  a  30o angle.  The mask made of silicone,  consists  of a cuff, 
which is inflatable through an inflation tube and a self – sealing pilot balloon. 
There are two vertical bars at the junction of the tube and the mask, which are 
designed to prevent the epiglottis from falling into the aperture of the tube.
A black line runs longitudinally along the posterior aspect of the tube to 
orient  it  after  placement.  A  standard  15mm  connection  is  present  at  the 
machine end.
Initially the LMA was introduced in 4 sizes. The design of the mask is  
based on the shape of the hypopharynx and not the larynx, hence the higher  
and  more  anterior  position  of  the  larynx  in  children  does  not  affect  the  
design  of  the  mask,  and  the  smaller  sizes  are  scaled  down  models  of  the  
adult size.
Available Laryngeal Mask Airways
S
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Cm Inflation 
volume
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1 8 Upto 4ml Neonates / infants upto 5 kg
1
.
5
10 Upto 7ml Infants between 5 – 10 kg
2 11.0 Upto 
10ml 
Children between 10 – 20 kg
2
.
5
12.5 10-14ml Children between 20 – 30 kg
3 16 15- 20ml Children and small adults over 30 kg
4 16 20-30ml Normal adults
5 18 30-40ml Large adults
  
Various types :
1. Standard LMA
2. Flexible LMA (reinforced LMA)
3. Short tube LMA
4. LMA Unique (Disposable LMA)
5. Intubating LMA (LMA fastrach)
6. LMA Pro – Seal
Preparation :
The cuff is fully deflated by pressing the hollow side down onto a clean 
flat surface, with two fingers pressing the tip flat. The deflated cuff should be 
free  from wrinkle  and its  rim should  face  away  from the  mask  apature.  This 
imparts  rigidity  to  the cuff.  A lubricant  is  applied to the posterior  surface of 
the cuff.
Placement:
Standard Technique :
The LMA can be placed with or without muscle relaxants. The patient is 
placed in  the  sniffing  position  (neck flexed  and head  extended).  The  head  is 
held  in  slight  extension  by  having  the  nonintubating  hand  stabilize  the 
occiput.  The  jaw is  allowed to  fall  open or  is  held open by an  assistant.  The 
device is held between the thumb and index finger as close as possible to the 
junction of the tube and the mask. The distal tip of the deflated cuff is pressed 
against  the  hard  palate  and  the  LMA  is  advanced,  using  the  index  finger  to 
guide  the  tube  over  the  back  of  the  tongue.  The  tube  is  advanced  until  a 
characteristic resistance is felt as the upper oesophageal sphincter is engaged. 
The hand is taken out.  Without holding the tube,  the cuff  is  inflated with the 
appropriate amount of air to achieve a proper seal.
The  longitudinal  blackline  on  the  shaft  of  the  tube  should  lie  in  the 
midline against  the upper lip.  When correctly positioned,  the tip of  the LMA 
cuff  lies  at  the  base  of  the  hypopharynx  against  the  upper  oesophageal 
sphincter,  the  sides  lie  in  the  piriform  fossae,  and  the  upper  border  of  the 
mask lies at the base of the tongue pushing it forward.
Modified techniques :
1. Lateral approach
2. Partially inflated cuff
3. By using a laryngoscope
Removal :
     The LMA is tolerated well  even in light planes of anaesthesia and can be 
left  in  place  during  emergence.  The  LMA  should  not  be  removed  in  light 
planes of anaesthesia.
The  overall  role  of  the  LMA  in  clinical  anaesthesia  appears  to  lie 
between  that  of  the  facemask  and  that  of  the  endotracheal  tube,  because  it 
provides  more  airway  security  than  the  former  but  not  the  reliable  airway 
protection and maintenance of the latter.
PHARMACOLOGY OF KETAMINE 
AND LIDOCAINE SPRAY
Physical properties :
Ketamine  is  a  2-0-chlorophenyl–2-methylaminocyclo  hexanone 
hydrochloride.  It  is  a  white  crystalline  substance  with  a  characteristic  smell. 
Readily soluble in water.
pH 3.5 – 4.1 in 10% solution. Supplied as 1,5 and 10% solutions.
PHARMACOKINETICS :
Absorption and Distribution :
  Ketamine  is  administered  by  either  the  intravenous  or  intramuscular 
route.  Peak  plasma  levels  are  usually  achieved  within  10  –  15  minutes  after 
intramuscular injection.
Ketamine is more lipid – soluble and less protein bound than thiopental; 
it is equally ionized at physiological pH.
These characteristics, along with a ketamine induced increase in cerebral 
blood  flow  and  cardiac  output,  lead  to  rapid  uptake  and  subsequent 
redistribution (Distribution half life is 10 – 15mts). Once again, awakening is 
due to redistribution to peripheral compartments.
Biotransformation :
Ketamine is  biotransformed in  the liver  to several  metabolites,  some of 
which  (eg.  norketamine)  retain  anaesthetic  activity.  Induction  of  hepatic 
enzymes  may  partially  explain  the  development  of  tolerance  in  patients  who 
receive multiple doses of ketamine. Extensive hepatic uptake (extraction ratio 
of  0.9)  explains  ketamine’s  relatively  short  elimination  half  –  life  (2  hours). 
End products of biotransformation are excreted renally.
PHARMACODYNAMICS:
Effect on Cardiovascular System:
Ketamine  increases  arterial  blood  pressure,  heartrate,  and  Cardiac 
output.  These indirect  cardiovascular effects are due to central stimulation of 
the  sympathetic  nervous  system  and  inhibition  of  the  reuptake  of  nor-
epinephrine.  Accompanying  these  changes  are  increase  in  pulmonary  artery 
pressure and myocardial work. For these reasons, ketamine should be avoided 
in  patients  with  coronary  artery  disease,  hypertension,  Congestive  Heart 
Failure  and aneurysms.  These indirect  effects  are  often beneficial  to  patients 
with acute hypovolemic shock.
Respiratory System:
Ventilatory drive is minimally affected by the customary induction doses 
of  ketamine,  although rapid intravenous  bolus  administration or  pretreatment 
with opioids occasionally produce apnea. It is a potent bronchodilator, making 
it a good induction agent for asthmatic patients. Upper airway reflexes remain 
intact. The increased salivation associated with ketamine can be attenuated by 
premedicaton with an anticholinergic agent.  
Central Nervous System:
Ketamine  increases  cerebral  O2 consumption,  CBF  and  Intra  Cranial 
Pressure.  These  effects  preclude  its  use  in  patients  with  space  –  occupying 
intracranial  lesions.  Undesirable  psychotomimetic  side  effects  during 
emergence  and  recovery  are  less  common  in  children  and  in  patients  
premedicated with benzodiazepines. Of the nonvolatile agents, ketamine may 
be  the  closest  to  being a  ‘complete’  anaesthetic  since  it  induces  analgesia,  
amnesia and unconsiousness.
Adverse reactions :
1. Hypertension, tachycardia, rashes
2. Vivid unpleasant dreams occur, and occasionally true hallucinations. The 
incidence  of  these  emergence  phenomenon  increases  with  age,  being 
about 5% under 5 years of age and 50% in adulthood. 
Clinical uses and doses :
Adults → 1 – 2 mg/kg, IV and supplementary doses of 0.5 mg/kg.
Intramuscular 10mg/kg.
IV infusion rate 40µg/kg/min.
Onset – 1min (IV) 10 min (IM).
Uses
1. As the sole agent for minor operations.
2. As an induction agent before general anaesthesia.
3. For induction of anaesthesia in small children
4. When maintenance of BP is important, eg: in states of shock and in some 
poor – risk patients and in the elderly.
Xylocaine spray 
 It is a clear liquid with an odour of ethanol, menthol and banana. The 
active ingredient is dissolved in a mixture of water, ethanol and polyethylene 
glycol.
Action  :  Causes  a  reversible  blockade  of  impulse  propagation  along  nerve 
fibres  by  preventing  the  inward  movement  of  sodium ions  through the  nerve 
membrane.
Pharamacokinetics : 
Lignocaine  is  absorbed  following  topical  administration  to  mucous 
membrane.  In  general,  the  rate  of  absorption  of  local  anesthetic  agents 
following  topical  application  is  most  rapid  after  intratracheal  and  bronchial 
administration.
Normally 64% of lidocaine is  bound to plasma proteins,  mainly alpha-1 
acid  glycoprotein  but  also  to  albumin.  Lignocaine  crosses  the  blood  brain 
barrier by passive diffusion.
Elimination pathyway is by liver metabolism, 90% excreted in the form 
of various metabolites and less  than 10% is excreted unchanged in the urine. 
The  elimination  half  –  life  of  lignocaine  following  an  intravenous  bolus 
injection  is  typically  1.5  -  2  hours.  Half  life  may  be  prolonged  two  fold  or 
more in patients with liver dysfunction.
   Adverse  effects  become  apparent  with  increasing  venous  plasma  levels 
above 6.0µg free base / ml.
Indications : gynaecological procedures
Introduction  of  instruments,  tubes  and  catheters  into 
respiratory and GI tracts 
Dental practice
Dosage and administration :
Duration : 10 – 15 minutes
Anaesthesia occurs with 1 – 5 minutes
(10% solution) each actuations of the metered dose delivers 10 mg lignocaine 
base.
In children less than 12 years of age the dose should not exceed 3 mg/kg 
(6 metered dose in an infant weighing 20 kg). In children less than 3 years of 
age less concentrated lignocaine solutions are recommended.
Contraindication – Hypersensitivity to amide local anesthetics.
Adverse effects –
1. Local reactions – irritation, hoarseness may occur
2. Allergic reactions (< 0.1%)  
3. Acute systemic toxicity
PHARMACOLOGY OF PROPOFOL
Physical  properties :  Propofol  is  2,6,  diisopropylphenol.  It  is  insoluble  in 
water  and  was  initially  prepared  with  cremophor  EL.  Since  there  was 
complement  mediated  adverse  reaction  to  cremophor  EL,  it  is  presently 
formulated in a 1% oil  in water emulsion containing 10% soyabean oil,  1.2% 
egg  phosphatide  and  2.25%  glycerol.  It  has  a  pKa  of  10.76.  Its  molecular 
weight  178.3.  pH  –  7.  It  is  currently  available  as  a  1%  solution  in  20ml. 
(10mg/ml) ampoules and 50 and 100 ml bottles containing 1% or 2% solution.
Pharmacokinetics
It is best described by a three compartment model. After  a  single 
bolus dose two distribution phases are seen.  The first  phase has a half life of 
1.8 – 8.3 minutes. This is followed by a phase of slow distribution with a half 
life  of  30  –  60  minutes.  It  is  during  the  second  phase  that  significant 
metabolism occurs.
Distribution 
The  central  compartment  can  be  loaded  by  administering  a  single  dose 
and starting  a  continuous  infusion  at  the  same time.  There  is  a  difference  in 
concentration achieved at the effector site  in the brain as compared to blood. 
The difference is due to a delay in the transfer of the drug from blood to the 
effector  site.  It  has  high  plasma  protein  binding  capacity  especially  with 
albumin and haemoglobin.
Metabolism :
 It  has  large  volume  of  distribution.  Redistribution  occurs  into  muscle, 
fat  and poorly perfused tissues.  It  undergoes extensive hepatic metabolism to 
conjugates  which  are  eliminated  in  the  urine.  The  terminal  half  life  ranges 
from 300 – 700minutes.
Pharmacodynamics
Effect on Central Nervous System: 
Propofol  is  primarily  a  hypnotic.  Anesthesia  is  induced  within  20  –  40 
seconds after  IV administration. There is a delay in disappearance of eyelash 
reflex.  Loss of  verbal  contact  is  a  better  end point.  EEG frequency decreases 
and amplitude increases. It reduces the duration of seizures induced by ECT in 
humans.
Effect on Cardiovascular system:
 In  healthy  patients  arterial  pressure  decreases  to  a  greater  degree  after 
induction  of  anaesthesia  with  propofol  than  with  thiopentone.  The  reduction 
results  primarily  from  vasodilation  although  there  is  a  slight  negative 
inotropic effect.
The  degree  of  hypotension  is  substantially  reduced  by  decreasing  the 
rate of administration of the drug.
The  pressor  response  to  tracheal  intubation  is  attenuated  to  a  greater 
degree  by  propofol  than  thiopentone.  It  has  been  suggested  that  propofol 
resets rather than inhibits the baroreceptor reflex.
Both  myocardial  blood  flow  and  myocardial  oxygen  consumption  are 
significantly reduced. Hence myocardial O2 supply demand ratio is preserved.
Effect on Respiratory System :
 After  induction apnea occurs  more commonly and for  a  longer  duration 
than  with  Thiopentone.  During  infusion  of  propofol,  tidal  volume is  reduced 
and respiratory rate is increased than in the conscious state.
It  has  no  effect  on  bronchial  smooth  muscle  and  laryngospasm  is 
particularly uncommon.
Laryngeal  reflexes  are  suppressed  to  a  greater  extent  and  propofol  is 
regarded as the agent of choice when laryngeal mask airway is to be used.
Effect on skeletal muscle:
  Tone  is  reduced  but  movements  may  occur  in  response  to  surgical 
stimulation.
Effect on GIT: No effect on GI motility in animals.
Effect on Hepatorenal system :
     Hepatic  blood  flow  is  decreased  by  reduction  in  arterial  pressure  and 
cardiac  output.  Liver  function  tests  are  not  altered.  There  is  a  transient 
decrease in renal function.
Effect on endocrine system
 Plasma  concentrations  of  cortisol  are  decreased  after  administration  of 
propofol.
Adverse effect :
1. Cardiovascular depression
Unless given very slowly, depression following a bolus dose of propofol 
is greater than that associated with a bolus dose of barbiturate and is likely to 
cause  profound  hypotension  in  hypovolemic  or  previously  hypertensive 
patients.
2. Respiratory depression :
Apnea is more common and of longer duration than with thiopentone.
3. Excitatory phenomenon
These are more frequent than with thiopentone.
4. Pain on injection 
This  occurs  in  upto  40%  of  patient.  The  incidence  is  reduced  when  a 
small dose of lignocaine is injected shortly before propofol.
5.Allergic reaction
Skin  rashes  occur  occasionally  and  anaphylactic  reactions  have  also 
been reported.
Uses and doses of propofol
Adults 
Induction 1 – 2.5mg/kg IV
Maintenance 50-150mcg/kg/min IV
Sedation 25 – 75 mcg/kg/min IV.
Children
Induction 2.5 – 3.5mg/kg/ IV administered over 20 – 30 seconds.
Maintenance 125 – 300 mcg/kg/min (7.5 - 18mg/kg/hr)
The ED95 induction dose is increased in children because the volume of 
the central compartment is 50% larger and clearance rate is 25% higher when 
compared to adults.
Contraindications for Propofol :
1. Airway obstruction
2. Hypersensitivity 
Mechanism of action of Propofol :
Pharmacologic  data  suggests  that  atleast  some  of  the  CNS  actions  of 
propofol  are mediated by the GABA receptor.  Propofol  also augments GABA 
induced neuronal inhibition of cerebral cortex.
Propofol  binding  to  the  GABA receptor  is  at  a  site  distinct  from those 
for barbiturates, benzodiazepines, or steroids.
The anesthetic  effects  are  probably  mediated by mechanisms other  than 
those on the GABA receptors.
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tube.
8. Lopez ML et al (1999). They compared patient outcome for propofol vs 
sevoflurane  with  the  LMA  using  either  spontaneous  breathing  or 
pressure  controlled  ventilation.  They  concluded  that  the  techniques 
using  propofol  and  sevoflurane  are  equally  suitable  for  induction  and 
maintenance of anaesthesia with the LMA in children undergoing minor 
surgery  below  the  umbilicus.  Emergence  is  more  rapid,  but 
postoperative agitation more common with sevoflurance.
9. Mamaya B et al., (2002). The efficacy and safety of the smallest size of 
the cuffed oropharyngeal  airway (COPA) for  school  age,  spontaneously 
breathing  children  was  investigated  and  compared  with  the  laryngeal 
mask  airway  (LMA).  The  COPA  is  a  good  extratracheal  airway  that 
provides new possibilities for airway management in school age children 
with an  adequate  and well  sealed  airway,  during spontaneous  breathing 
or during short – term assisted manual ventilation.
10. Joshi  GP  et  al.,  (1998). They  compared  anaesthetic  requirements, 
recovery  times  and  postoperative  side  effects  when  a  laryngeal  mask 
airway was used as an alternative to the tracheal tube during ambulatory 
anaesthesia.  Use  of  the  laryngeal  mask  airway  can  obviate  the  need  for 
insertion of a tracheal tube for many ambulatory surgery procedures, and 
thereby decrease the incidence of post operative sore throats.
11. Nagais  et  al.,  (2000). They  modified  the  technique  for  laryngeal  mask 
airway  insertion  in  children.  It  involves  inserting  a  two  -  thirds  inflated 
LMA with  its  lumen  facing  laterally  towards  left  and  then  rotating  it  90 
degrees clockwise as it passes downwards into position behind the larynx. 
Then the cuff is inflated fully. A satisfactory airway was achieved in all of 
the  children  who  participated  in  the  survey.   There  were  no  significant 
differences in vital signs between pre and post – insertion.
12. In  1985  McCulloch  and  coworkers studied  the  incidence  of  pain  on 
injection  of  Propofol.  The  incidence  of  pain  was  37.5% on injection into 
the  dorsal  hand  veins.  The  incidence  of  pain  was  only  partially  reduced 
when using intravenous lidocaine.
13. In  1922  Jan  Manschot  et  al studied  the  age  related  difference  in 
propofol  requirements  for  induction  in  healthy  children  aged  3  –  15 
years,  using  1.5mg/kg  to  3.5mg/kg.  There  was  significant  decrease  in 
MAP and this occurred in all dose and age groups.
14. In 1994,  Hanallah et  al conducted a  study on one hundred children (3 – 
12  years)  scheduled  for  day  care  surgery  and  compared  propofol 
anaesthesia  with  thiopentone  and  halothane.  The  study  evaluated  the 
hemodynamic  changes  during induction of  anaesthesia  and the speed and 
quality of recovery from anaesthesia.
The results were
i. 3mg/kg  of  bolus  propofol  produced  rapid  and  smooth  induction  of 
anesthesia in children.
ii. 4% of patients who received propofol had pain on injection
Samar  Kandi  AH  et  al.,  (1995).  A  prospective  study    to  assess  airway 
protection   by  the  LMA in  paediatric  patients,  using  methylene  blue  and the 
fibroptic  bronchoscope to  view the  inside of  the mask,  to  detect  any leakage 
of the dye.  All patients were allowed to breath spontaneously over an Ayre’s 
T piece. No serious complications occurred in any patients.
Gursoy  et  al.,  (1996). The  safety  of  positive  pressure  ventilation  when 
using the size 2 LMA in children were studied. The LMA cuff was inflated 
in  incremental  steps  to  achieve  a  cuff  leak  pressure  of  15cm  H2O. 
Abdominal  circumference  was  measured  before  and  after  PPV  in  study 
patients, as well as in a control group managed with tracheal intubation. The 
size  2  LMA provides  an  effective  airway  for  PPV.  Mild  gastric  distension 
often  occurs.  They  conclude  that  with  certain  precautions  described  in  the 
text, the size 2 LMA provides a relatively safe airway for PPV in children.
15. Frantantonio  R  et  al  (2000).  To  assess  the  incidence  of  postoperative 
respiratory complications in patients recently suffering from inflammation 
of the upper respiratory tract in whom a LMA or uncuffed orotracheal tube 
have  been  used.  The  frequency  of  adverse  respiratory  events  increases 
significantly  in  URI  patients  with  both  LMA  and  the  tracheal  tube.  In 
recent  URI,  it  would  seem  appropriate  to  avoid  tracheal  intubation,  if 
possible, preferring the LMA.
Ofer  R  et  al.,  (1997). In  case  of  craniofacial  and  mandibulofacial 
malformations,  which  are  mostly  treated  during  childhood,  difficult 
intubation conductions  must  generally  be expected.  In  such cases,  the  LMA 
an alternative instrument  for  use in endotracheal  intubation is  a new aid for 
ventilation. It is not only a ventilation aid, but also a valuable too in difficult 
intubation conditions.
MATERIAL AND METHODS
The study was conducted in 50 paediatric patients of either sex, between 
the age group of 3 – 12 years. They belonged to ASA I and II and were posted 
for elective surgery.
Those  who  have  neuromuscular  disease,  psychiatric  disorders,  seizure 
disorders,  respiratory  tract  infection,  or  a  history  of  allergy  or  asthma  were 
excluded.  Patients  were  randomized  into  two  groups  to  receive  propofol  or 
ketamine with lidocaine spray.
Informed written consent was obtained from all parents.
Study group (Group K) – Ketamine 3mg/kg with Xylocaine spray
Control group (Group P) – Propofol 3mg/kg.
Premedication :
Intravenous  line  with  Balanced  salt  solution  was  established  in  all 
patients. 
Patients were premedicated with
Inj. MIDAZOLAM 0.05mg/kg IV
Inj. GLYCOPYROLATE 0.005 mg/kg IV
5 minutes before induction
Monitoring :
Precordial stethoscope
Pulse oximetry
Electrocardiogram
NIBP monitor
Induction :
Ketamine group
One  minute  before  induction  lidocaine  spray  (10%)  was  applied  to  the 
oropharynx.
Body weight between 10 – 20 kg: spray twice,
20 – 30kg: spray 3 times 
> 30 kg : spray 4 times. 
Ketamine 3mg/kg was injected over one minute. Immediately after loss of lid 
reflex,  a  face  mask  was  gently  put  onto  the  face  with  4L/min  of  oxygen.  If 
apnea occurred,  controlled ventilation was instituted.  The LMA was inserted. 
If  spontaneous  ventilation  was  lost,  LMA  position  and  airway  patency  were 
checked  by  gentle  manual  ventilation.  If  spontaneous  ventilation  was  active, 
LMA  position  and  airway  patency  were  clinically  checked  by  regular, 
rhythmic reservoir bag movement.
Propofol group :
The calculated dose (3mg/kg) of propofol was injected over 15 seconds. 
Immediately after injection, 3ml of saline was used to flush the drug from the 
IV line.
After  1min,  LMA  was  inserted.  If  spontaneous  ventilation  was  lost, 
LMA position and airway patency were checked by gentle manual ventilation. 
If there was airway obstruction before insertion, mask ventilation with 4L/min 
of  oxygen  was  administered.  The  respiratory  rate  was  monitored.  If  apnea 
(cessation  of  breathing  for  >  20s)  occurred  controlled  ventilation  was 
instituted.
The  conditions  for  LMA  insertion  and  patient  responses  in  both  the 
groups were tabulated, as follows
1. Self respiration
   a. Satisfactory (Active)
   b. Acceptable (weaker than active)
   c. Unsatisfactory (apnea)
2. Airway obstruction 
a. None
b. Partial,  relived  by  mandibular  lift,  or  if  apnea,  smooth  mask 
ventilation, with minimal jaw thrust.
c. More severe than acceptable criteria.
3. Jaw relaxation
a. Satisfactory (ideal).
b. Acceptable (Not ideal but permits easy opening of mouth).
c. Unacceptable (None).
Responses after LMA insertion 
            1.  Laryngospasm.
    a.None
    b.Mild (spontaneous relief)
    c.Moderate (relieved by Positive Pressure)
    d.Severe (relieved by Scoline)
2. Coughing, gagging, swallowing, tongue movement.
a.Absent
b.Minimal  (Some  movement  but  did  not  affect  positioning  of 
LMA).
c.Moderate (holding required no need for inhalational anaesthetic)
d.Severe (additional dose of drug needed)
3. Head and Limb movements
a.Absent
b.Mild (no restraint necessary)
c.Moderate (some restraint necessary discontinued immediately).
d.Severe (additional dose needed).
The results were tabulated and statistically analysed. 
Chi-square test was used to arrive at the p value. The significance of all the 
tests was compared with available studies and results were arrived at. 
OBSERVATION AND RESULTS
This study was conducted on 50 patients who were divided into 2 groups
Group K: Ketamine 3mg/kg IV with lidocaine spray
Group P: Propofol 3mg /kg
The age, body weight and sex distribution of all 50 patients are shown in 
table  –  A.  There  were  no  wide  variations  in  the  age  or  body  weight  of  the 
study groups. The surgical procedures were mainly of general surgeries below 
umbilicus.
TABLE A
Demographical data (Mean ±  SD)
Parameter Group K Group P
Age (Years) 7.5 ± 4.5 8.0 ± 4
Weight (kg) 19 ± 11 21 ± 11
Sex (M : F) 13 : 12 12 : 13
Comparison of conditions for LMA insertion
Three conditions such as self respiration, airway obstruction and jaw 
relaxation were assessed in both groups and the results were tabulated as 
shown in table B,C,D.
TABLE B
   Self respiration
Self respiration Group K (n = 25) Group P (n = 25)
Satisfactory (active) 22 (88%) 16 (64%)
Acceptable (Weaker 
than active)
3 (12%) 8 (32%)
Unsatisfactory 
(apnea)
- 1 (4%)
(P < 0.05) statistically significant (X2 = 3.95)
In group K patients respiration was active in 88% as compared to group 
P (64%). 36% of group P patients had weaker than active respiration or apnea 
(cessation  of  breathing  >20  sec)  before  LMA  insertion.  In  them  respiration 
was  assisted  with  mask  ventilation.  But  only  12%  of  group  K  patients  had 
weaker  than  active  respiration.  There  was  statistical  significant  difference 
between the two groups.
TABLE C
Airway obstruction Group K
(n = 25)
Group P
(n = 25)
Satisfactory (none) 24 (96%) 12 (48%)
Acceptable (partial, relieved by 
mandibular lift or if apnea, mask 
ventilation with minimal jaw thrust)
1 (4%) 13 (52%)
 Unsatisfactory (more severe) - -
P < 0.001 statistically significant (X2 = 14.29) 
Airway  obstruction  was  more  in  group  P  patients  (52%).  In  group  K 
patients  only  4% had airway obstruction.  In  both the  groups  obstruction  was 
relieved by mandibular lift and mask ventilation with minimal jaw thrust.
TABLE D
Jaw Relaxation
Jaw relaxation Group K
(n =25)
Group P 
(n = 25)
Satisfactory (Ideal) 14 (56%) 19 (76%)
Acceptable (not ideal but 
permits easy opening)
10 (40%) 4 (16%)
Unsatisfactory (none) 1 (4%) 2 (8%)
P > 0.05 not significant (X2 = 2.23)
In  both  the  groups,  jaw  relaxation  was  minimal  for  LMA  insertion  in 
considerable  number  of  patients.  Difficulty  in  mouth  opening  is  more  in 
(44%)  group  K  patients  than  in  group  P  (24%).  But  the  results  are  not 
statistically significant.
Comparison of response after LMA insertion.
TABLE E
LARYNGOSPASM
Laryngospasm Group K 
(n = 25)
Group P 
(n = 25)
None 24 (96%) 25 (100%)
Mild (Spontaneous relief) 1 (4%) -
Moderate (relieved by applying 
positive pressure)
- -
Severe (relieved by scoline) - -
In  both  the  groups  there  was  no  incidence  of  life  threatening 
laryngospasm.  In  our  study,  only  one  patient  had  mild  laryngospasm  after 
LMA insertion, which was spontaneously relieved.
TABLE F
COUGHING, GAGGING, SWALLOWING, TONGUE MOVEMENTS
Coughing, Gagging, 
Swallowing, Tongue 
Movements
Group K 
(n – 25)
Group P 
(n = 25)
Absent 15 (60%) 13 (52%)
Minimal (some movement but 
didn’t affect positioning of 
LMA)
6 (24%) 8 (32%)
Moderate (holding required) 4 (16%) 2 (8%)
Severe (additional dose of drug 
needed)
- 2 (8%)
P > 0.05 statistically not significant. 
In  both  the  groups  coughing,  gagging,  swallowing  and  tongue 
movements  occurred  in  considerable  number  of  patients.  There  was  no 
statistically significant difference in results between the two groups.
TABLE G
HEAD AND LIMB MOVEMENTS
Head and Limb Movements Group K 
(n – 25)
Group P 
(n = 25)
Absent 22 (88%) 16 (64%)
Mild (no restraint necessary) - -
Moderate (some restraint 
necessary discontinued 
immediately) 
3 (12%) 9 (36%)
Severe (additional dose needed) - -
P > 0.05 Statistically significant 
Head  and  limb  movements  are  more  in  group  P  patients  (36%)  than  in 
Group K (12%). These results show a statistically significant difference.
  
DISCUSSION
Laryngeal mask airway introduced by Brain in 1983 as an alternative to 
tracheal intubation in patients when conventional endotracheal intubation is 
either difficult or impossible.
Ketamine is well – known for its airway maintaining activity as 
well as for its increases in heart rate and cardiac output. To take advantage of 
airway maintaining activity and to suppress increased airway reflexes, 
lidocaine spray was added to the preparation of the patients before the 
injection of ketamine
Conditions for laryngeal mask airway insertion.
Self respiration:    
Jae – Hyon Bahk et al,  showed the effectiveness of ketamine for LMA 
insertion.  Ketamine  maintains  spontaneous  respiration  effectively  than 
propofol in children.
 In our study, there was less incidence of apnea in ketamine group than 
in propofol group.
Airway obstruction :
Bhak et al,  showed that airway obstruction was experienced after every 
dose of propofol in paediatric patients.
In  our  study,  children  who  received  propofol  had  significant  airway 
obstruction than in children who received ketamine.
Jaw relaxation :
 In  both  the  groups  jaw  relaxation  was  minimal  for  LMA  insertion  in 
considerable number of patients.
Responses after laryngeal mask airway insertion.
Laryngospasm :
 Cook TM Seavel  et  al,  compared topical  and intravenous lignocaine to 
aid insertion of LMA with thiopentone. The group who had topical lignocaine 
had a lower incidence of laryngospasm.
In out study, no patients had severe laryngospasm.
Coughing, gagging, swallowing, tongue movements
Jae  –  Hyon  Bahk  et  al,  compared  responses  after  LMA  insertion  in 
patients  who  received  ketamine  and  propofol.  They  showed  that  both  the 
groups had similar results. 
In  our  study,  both  the  groups  of  patients  had  coughing,  gagging, 
swallowing and tongue movements after LMA insertion. 
Head and limb movements:
 In our study, there was significant difference between the two groups in 
limb  movements.  More  number  of  propofol  group  patients  had  limb 
movements than ketamine group.
SUMMARY
In our study, there was better conditions for laryngeal mask airway 
insertion regarding self respiration. It was better in the ketamine with 
lignocaine group as compared to the propofol group during LMA insertion. 
There was decreased incidence of airway obstruction in ketamine group 
as compared to the Propofol group.
There was no significant difference between the two groups as far as jaw 
relaxation was concerned.
Response to LMA insertion (laryngospasm, coughing, gagging) was also 
not significant between the two groups.
Haemodynamically, ketamine produced an increase in the heart rate 
when compared to propofol.
CONCLUSION
From the study, there was better conditions for laryngeal mask airway 
insertion regarding self respiration. It was better in the ketamine with 
lignocaine group as compared to the propofol group during LMA insertion. 
There was decreased incidence of airway obstruction in ketamine group 
as compared to the Propofol group.
There was no significant difference between the two groups as far as jaw 
relaxation was concerned.
Response to LMA insertion (laryngospasm, coughing, gagging) was also 
not significant between the two groups.
 we concluded that ketamine with lidocaine spray in the dose of 3mg/kg 
can be used for LMA insertion in children. 
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Effects of propofol on cardiovascular system.
PROFORMA
Comparison of Ketamine and Lidocaine spray with propofol for the  insertion of 
LMA in children
Name : 
Age : Sex :
Diagnosis : Surgery :
Body weight:
ASA status  :
CVS : RS :
 
Premedication:(5 minutes before induction)
Inj. Midazolam 0.05 mg/kg      IV-
Inj. Glycopyrrolate 0.05 mg/kg      IV-
Monitors:
Precordial stethoscope-
ECG
Pulse oximetry
BP monitoring
Group K Group P
Propofol 3.0 mg/kg (15 sec). Ketamine 3.0 mg/kg (1 min.)
Liodcaine spray (10%)
Conditions for Insertion of LMA
1. Self respiration
         Group  K           Group  P
a. Satisfactory 
(active)
b. Acceptable 
(weaker than 
active)
c. Unsatisfactory 
(apnea)
2. Airway obstruction
           Group K            Group P
a. Satisfactory 
(none)
b. Acceptable 
(partial, relieved by 
mandibular lift or if 
apnea, mask 
ventilation with 
minimal jaw thrust)
c. Unsatisfactory 
(more severe)
3. Jaw relaxation
           Group K            Group P
a. Satisfactory (ideal)
b. Acceptable (not 
ideal but permits easy 
opening)
c. Unsatisfactory 
(none)
Responses after LMA Insertion
4. Laryngospasm
Group K Group P
a. None
b. Mild (spontaneous relief)
c. Moderate (relieved by applying PP)
d. Severe (relieved by Scoline)
5. Unsatisfactory responses (coughing, gagging, swallowing, tongue movement)
Group K Group P
a. Absent 
b. Minimal (some movement but did 
not affect positioning of LMA)
c. Moderate (holding required, no 
need for inhalation anaesthetic)
d. Severe (additional dose of drug 
needed)
6. Head and limb movements
Group K Group P
a. absent  
b. mild (no restraint was necessary)
c. moderate (some restraint necessary 
discontinue immediately)
d. severe (additional dose needed)
MASTER CHART
Ketamine Group
S.N NAME
AGE 
(YRS) 
& SEX
WT 
(kg) SURGERY
CONDITIONS ON 
INSERTION
RESPONSES AFTER 
INSERTION
SR AO JR L CGT HL
PRE 
INDUCTION 
HEART 
RATE/ MIN
GIRIJA 6.5/F 12k
g
Dislocation hip/
open Reduction
S S S N Ab Ab 96
SARAVANAN 12/M 32k
g
Hypospadias/
Urethroplasty
S S S N Ab Ab 82
GANESH 7/M 14k
g
Penile hypospedias
Urethroplasty
A S S N MI Ab 86
HARIHARAN 9/M 22k
g
Illizarovav fixation tibia S S S N Ab Ab 82
JAYABHARATHA
N
8/M 19k
g
Urethroplasty S S A N MI MO 92
MANIKANDAN 3/M 8kg Analstenosis
/Anoplasty
S S S N Ab Ab 110
KUMAR 5/M 13k
g
Herniotomy S S A N Ab Ab 100
RAMYA 10/M 21k
g
Cystoscopy S A S N MI Ab 92
RAKESH 11/M 26k
g
Hypospadias/
Urethroplasty
S S S N Ab Ab 96
SENTHILKUMAR 8/M 20k
g
Herniotomy Rt S S U N MI Ab 92
LAVANYA 9/F 18k
g
ORIF® tibia S S S N Ab Ab 96
SUGANTHI 4/F 9kg CTEV / illizarov S S S N MO MO 102
RAMESH 4/M 10k
g
Herniotomy S S A M Ab Ab 106
KUMARI 6/F 14k
g
B/L Herniotomy S S S N MO Ab 96
THILAK 7/M 16k
g
Coronalhypospadias/
urethroplasty
S S S N Ab Ab 102
BALAMANI 12/F 28k
g
Skin graft A S S N Ab Ab 96
VINODHA 8/F 20k
g
Herniotomy Rt S S S N MI Ab 92
FILOMINA 9/F 21k
g
Cystoscopy S S A N Ab Ab 102
PANDIAN 6/M 12k
g
Encysted hydiocale/
Ligation
S S S N Ab Ab 98
VIKRAM 7/M 16k
g
Herniotomy Rt S S S N MO Ab 90
NISHA 5/F 15k
g
Anoplasty S S S N Ab Ab 96
VALLI 8/F 20k
g
Cystoscopy S S U N MI MO 96
KOLINCHI 10/F 22k
g
Circumcesion/Herniotomy A S S N Ab Ab 102
ALAGESAN 6/M 16k
g
Illizarov Rt. Leg S S S N Ab Ab 92
NIROSHA 4/F 13k
g
Herniotomy S S S N MI Ab 106
SR – Self Respiration L – Laryngospasm S – 
Satisfactory Ab - Absent
AO – Airway Obstruction CGT – Coughing,Gagging A – 
Acceptable N - None
JR – Jaw  Relaxation HL – Head and Limb Movement U – 
Unacceptable Mi – Minimal
Mo - Moderate
MASTER CHART
PROPOFOL GROUP
S. 
NO NAME
AGE 
(YRS) & 
SEX
WT (kg) SURGERY
CONDITIONS 
ON INSERTION
RESPONSES 
AFTER 
INSERTION
SR AO JR L CGT HL
INDUCTION
HEART RATE/ 
1. DILIRAJ 4/M 11kg Rt Herniotomy S S S S Ab Ab 96
2 ITHIKAS 4/M 12kg Hypospadias/urethrop
lasty
A S S S MI Ab 90
3 ARUNKUMAR 5/M 15kg Illizarov® tibia S S S S Ab MO 92
4 ANUSUYA 8/F 19kg R Herniotomy S A A S Ab Ab 100
5 MEENA 5/F 12kg Skin graft Rt. Thigh A A A S MI MO 106
6 JAYABALAN 6/M 13kg Herniotomy A S A S Ab MO 92
7 SABARIGIRI 4/M 10kg Hypospadias 
fistula/Repair
S A S S Ab Ab 126
8 RAJADURAI 10/F 20kg Penile Hypospadias 
fistula/Repair
U S S S MO Ab 88
9 DAVID 6/M 17kg Undescended testis
/ orchidopexy
S S S S Ab MO 102
10 KISHORE 4/M 12kg Herniotomy A S S S MI Ab 106
11 RAJALAKSHMI 12/F 24kg Cystoscopy S A A S SE Ab 88
12 LAVANYA 11/F 28kg CTEV/Illizarov S A S S Ab MO 82
13 MALA 9/F 22kg Club foot/Repair S S S S Ab Ab 86
14 KISHORE 7/M 20kg Herniotomy S A S S MI Ab 92
15 VIKRAM 6/M 12kg Herniotomy Rt S A S S SE Ab 100
16 BEEPA 5/F 13kg Dislocation hip/open 
reduction
S S S S Ab Ab 98
17 VINDHYA 4/F 11kg Herniotomy Rt A S S S MI MO 92
18 PRADARSHINI 12/F 22kg Anoplasty S A U S MI Ab 88
19 MUGANTHAN 9/M 18kg Circumcision 
/Herniotomy
S A S S MO MO 96
20 GAYATHRI 11/F 17kg Cystoscopy A S S S Ab Ab 88
21 SHANTHI 10/F 16kg Pv sac ligation A A S S MI MO 90
22 DINESH 8/M 18kg Herniotomy Lt S S U S Ab Ab 92
23 PRAKASH 9/M 24kg Hypospadias 
fistula/Repair
S A S S Ab MO 96
24 KARTHIK 10/F 22kg Skin graft Rt. Leg A A S S Ab Ab 82
25 RAMYA 11/F 22kg Slipped femoral 
epiphysis/ Repair
S A S S MI Ab 96
      SR – Self Respiration L – Laryngospasm S – Satisfactory
Ab - Absent
     AO – Airway Obstruction CGT – Coughing,Gagging A – Acceptable
N - None
     JR – Jaw  Relaxation HL – Head and Limb Movement U – Unacceptable
Mi – Minimal
Mo - Moderate

